WordNet
- of or relating to the spinal cord
- of or relating to bone marrow
PrepTutorEJDIC
- (体内にできる)新生物;腫瘍(しゅよう)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 造血腫瘍の分類 classification of the hematopoietic neoplasms
- 2. 骨髄増殖性腫瘍の概要 overview of the myeloproliferative neoplasms
- 3. Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis
- 4. 骨髄異形成症候群の臨床症状および診断 clinical manifestations and diagnosis of the myelodysplastic syndromes
- 5. 慢性骨髄性白血病の臨床症状および診断 clinical manifestations and diagnosis of chronic myeloid leukemia
English Journal
- CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.
- Tokuda K, Eguchi-Ishimae M, Yagi C, Kawabe M, Moritani K, Niiya T, Tauchi H, Ishii E, Eguchi M.SourceDepartment of Pediatrics, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
- Genes, chromosomes & cancer.Genes Chromosomes Cancer.2014 Jan;53(1):78-89. doi: 10.1002/gcc.22119. Epub 2013 Oct 21.
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a subtype of acute myeloid leukemia, affecting mainly the elderly. It is thought to be derived from plasmacytoid dendritic cell precursors, which frequently present as cutaneous lesions. We have made a detailed analysis of an infant with BPDCN,
- PMID 24142740
- TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
- Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Jeffrey Medeiros L, Khoury JD.SourceDepartment of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, King Saud University, Riyadh, Saudi Arabia.
- American journal of hematology.Am J Hematol.2013 Dec;88(12):1055-61. doi: 10.1002/ajh.23567. Epub 2013 Sep 30.
- Distinguishing blastic plasmacytoid dendritic cell neoplasm (BPDCN) from acute myeloid leukemia (AML) is gaining increased importance because of emerging differences in therapeutic approaches, and this distinction can be problematic in bone marrow specimens. We identified retrospectively 16 patients
- PMID 23940084
Japanese Journal
- 造血器腫瘍の新たな治療標的としてのマイクロRNA (特集 マイクロRNAと血液疾患)
- 北村 俊雄
- 血液内科 68(6), 800-804, 2014-06
- NAID 40020139553
- 転移性乳がんに対する^89Srを含む集学的治療後に非典型的な発症経過を呈した治療関連急性前骨髄球性白血病
- 宇津 欣和,青墳 信之,増田 真一,松浦 康弘,脇田 久
- 臨床血液 54(8), 759-763, 2013-08-30
- NAID 10031196293
Related Links
- CSv2 Colon, Rectum and Appendix Schema Presentation June 30, 2010 Version: 2.10 Incidence and Mortality Signs and Symptoms Risk Factors Overview of the Myeloid Neoplasms 4 Myeloid Neoplasm Characteristics 2011 estimates in the United States
- LeukoVantage , Myeloid Neoplasm Mutation Panel Test code(s) 92668 Question 1. What is the LeukoVantage panel? The LeukoVantage assay is a panel that detects myeloid neoplasm-associated mutations in 30 genes (Table).
Related Pictures
★リンクテーブル★
| 関連記事 | 「myeloid」「neoplasm」「myelo」 |
「myeloid」
- adj.
- 骨髄の、骨髄性の、骨髄球性の、ミエロイド
「neoplasm」
- n.
「myelo」
- comb form
- ex.